Table 4. Current clinical trials with mSCs.

Disease	Phase
Transplant rejection (GvHD, kidney transplant)	I–III
Morbus Crohn	III
Acute renal failure/acute kidney injury	I
Lupus nephritis	I/II
Diabetes mellitus	I/II–II
Chronic obstructive pulmonary disease	II
Liver failure	I/II
Multiple sclerosis	I/II
Cardiac disease	I/II–II
Bone and cartilage defects	I/II–II
Osteogenesis imperfecta	I
Cord blood expansion	I/II

Abbreviations: GvHD, graft-versus-host disease; mSC, mesenchymal stromal cell.